Ajala Adebisi MD is categorized under Business Services (Unclassified) in Jacksonville, FL and active since 2013.
Ajala Adebisi MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Adebisi Ajala at the company’s single location by writing to 807 Childrens Way, Jacksonville, Florida FL 32207 or by phoning (904) 697-3600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ajala Adebisi MD |
| Contact Person: | Adebisi Ajala |
| Address: | 807 Childrens Way, Jacksonville, Florida 32207 |
| Phone Number: | (904) 697-3600 |
| Website Address: | nemours.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Ajala Adebisi MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Adebisi Ajala for inquiries that concern Ajala Adebisi MD by calling the company number (904) 697-3600, as your correspondence is most welcome. Additionally, the physical location of the single location of Ajala Adebisi MD can be found at the coordinates 30.31216,-81.66332 as well as the street address 807 Childrens Way in Jacksonville, Florida 32207.
For its online presence, you may visit Ajala Adebisi MD’s website at nemours.org and engage with its social media outlets through on Twitter and on Facebook.